Summary
The conventional indirect immunofluorescence test of islet cell antibodies was recently improved by the development of a two-colour immunofluorescence assay using a monoclonal proinsulin antibody to detect islet B cells. The aim of this study was to test whether in this new assay the prevalence and titre of ICA were affected by the time of incubation carried out in the presence of aprotinin (Trasylol) as an inhibitor of proteolysis. The end-point titre of ICA was therefore determined in sera from 70 children aged 0.6 to 15 years with recent onset Type 1 (insulin-dependent) diabetes mellitus, 50 healthy control subjects and 97 non-diabetic siblings of Type 1 diabetic children. In the conventional twocolour assay, ICA was positive in 53/70 (76%) Type 1 diabetic patients, 1/50 control subjects and 2/97 siblings after 30 min incubation. Prolonged incubation for 18 h increased the prevalence of ICA positive samples to 62/70 (89%) in the diabetic patients and to 2/50 in the control subjects, while the prevalence among the siblings was unchanged. Of the ICA positive non-diabetic subjects, one control child has a father with Type 1 diabetes, and one of the siblings subsequently developed Type 1 diabetes. In the diabetic patients the median titre was 1:32 for the 30 min incubation, and it increased to 1:64 for the 18 h incubation (p<0.001). A marked prozone effect was seen; 16% of the samples from the Type 1 diabetic children sera were negative at a 1:2 dilution, but were found positive at higher dilutions. In conclusion, an 18 h incubation increases the end point titres and the prevalence of ICA in the two-colour ICA assay in Type 1 diabetic children of recent onset. The prevalence and levels of ICA among these patients may be larger than hitherto expected.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2: 1279–1283
MacCuich AC, Irvine JW, Barnes EW, Duncan LJP (1974) Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 2: 1529–1531
Lendrum R, Walker G (1975) Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1: 880–883
Lendrum R, Walker G, Cudworth AG, Theophanides C, Pyke DA, Bloom A, Gamble DR (1976) Islet cell antibodies in diabetes mellitus. Lancet 2: 1273–1276
Irvine WJ, McCallum CJ, Gray RS, Campbell CJ, Duncan LJP, Farquhar JW, Vaughan H, Morris PJ (1977) Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes 26: 138–147
Betterle C, Caretto A, Tiengo A, Trevisan A (1980) Complementfixing islet-cell antibodies in Type 1 diabetes and in susceptible patients with autoimmune diseases. Lancet 1: 1418–1419
Lernmark Å, Hagglöf B, Freedman Z, Irvine J, Ludvigsson J, Holmgren G (1981) A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia 20: 471–474
Kobayashi T, Sawano S, Sugimoto T, Itoh T, Kosaka K, Tanaka T, Suwa S (1983) Islet-cell antibodies in IDDM and NIDDM in a Japanese population. Tohoku J Exp Med 141 [Suppl]: 271–274
Bruining GJ, Molenaar J, Tuk CW, Lindeman J, Bruining HA, Marner B (1984) Clinical time-course and characteristics of islet cell cytoplasmic antibodies in childhood diabetes. Diabetologia 26: 24–29
Mustonen A, Knip M, Huttunen N-P, Puukka R, Käär M-L, Åkerblom HK (1984) Evidence of delayed beta-cell destruction in Type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies. Diabetologia 27: 421–426
Takahashi A, Tsujihata M, Yokota A, Yamaguchi Y, Ueda Y, Akazawa S, Miyake S, Nagataki S (1986) A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 378–382
Bottazzo GF, Gleichmann H (1986) Immunology and Diabetes Workshop: report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 29: 125–126
Gleichmann H, Bottazzo GF (1987) Progress towards standardisation of the cytoplasmic islet-cell antibody assay: analysis of the data presented at the first international workshop. Diabetes (in press)
Marner B, Agner T, Binder C, Lernmark Å, Nerup J, Mandrup-Poulsen T, Walldorff S (1985) Increased reduction in fasting Cpeptide is associated with islet cell antibodies in Type 1 (insulin-dependent) diabetic patients. Diabetologia 28: 875–880
Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long pre-diabetic in type 1 (insulin-dependent) diabetes mellitus. Lancet 2: 1363–1365
Madsen OD, Landin Olsson M, Bille G, Sundkvist G, Lernmark Å, Dahlqvist G, Ludvigsson J (1986) A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetologia 29: 115–118
Pilcher C, Elliott RB (1984) Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics. Lancet 1: 1352
Madsen OD, Larsen LI, Lernmark Å (1985) Diffusion of C-peptide but not proinsulin from islets in frozen sections of human pancreas identified by monoclonal antibodies. Biomed Biochim Acta 44: 133–136
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type 1 diabetes: possible monitors of active beta-cell damage. Lancet 1: 668–672
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paguette TL (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337–1339
Wilkin T, Armitage M, Casey C, Pyke DA, Hoskins PJ, Rodier M, Diaz JL, Leslie RDG (1985) Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1: 480–482
Arslanian SA, Becher DJ, Rabin B, Atchinson R, Eberhardt M, Cavender D, Dosman J, Drash AL (1985) Correlates of insulin autoantibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 34: 926–930
Ludvigsson J, Binder C (1985) The amount of insulin antibodies after insulin treatment is not related to insulin autoantibodies at onset of IDDM. Diabetes Res Clin Pract [Suppl 1]: 348
Atkinson MA, Maclaren NK, Riley WJ, Winter WE, Fisk DD, Spillar RP (1986) Are insulin autoantibodies markers for insulin-dependent diabetes mellitus? Diabetes 35: 894–898
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olsson, M.L., Sundkvist, G. & Lernmark, Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30, 327–332 (1987). https://doi.org/10.1007/BF00299026
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00299026